Skip to content

Early CPAP And Large Volume Minimally Invasive Surfactant (ECALMIST) in Preterm Infants With RDS

Feasibility of Using Early CPAP (Continuous Positive Airway Pressure) And Large Volume Minimal Invasive Surfactant Therapy (ECALMIST) in Preterm Infants With Respiratory Distress Syndrome (RDS)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01553292
Acronym
ECALMIST
Enrollment
21
Registered
2012-03-14
Start date
2012-04-30
Completion date
2012-09-30
Last updated
2013-07-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Respiratory Distress Syndrome

Keywords

Respiratory distress syndrome, Preterm infants, Vascular catheter, Surfactant, CPAP, ECALMIST

Brief summary

Modification of Minimally Invasive Surfactant Therapy (MIST) to a new technique called ECALMIST (Early CPAP And Large volume Minimal Invasive Surfactant). This modification is needed to adapt the use of large volume surfactant of 4-5 ml/kg. The ECALMIST will be used to deliver the large volume Surfactant that been used in Canada called BLES (about 5 ml for each 100 mg) to the preterm infants bellow 35 weeks gestation suffer from respiratory distress syndrome (RDS) in 1st 24 hours of life while maintained on CPAP.

Detailed description

The 5 ml/Kg surfactant is warm to room temperature. Using standard laryngoscope without premedication while the infant is maintained on continuous positive airway pressure (CPAP. The the laryngoscope should be removed after stabilizing the vascular catheter between 2 fingers at the level of lips (weight +6 cm). The surfactant will be administer by boluses of 0.25 -0.5 ml at a time over 20-30 seconds and 10 seconds apart while maintain the vital signs. The procedure should be stopped if the vital signs deteriorate, CPAP pressure and oxygen requirement might need to adjusted to restore baseline vital signs. If the vital signs remained unstable the catheter should be removed and the infant managed according by positive pressure ventilation (PPV) or intubation by endotracheal tube (ETT). At the end of the procedure the catheter should be flushed with 0.5 ml of air then catheter should be removed. FiO2 (fraction of inspired oxygen), oxygen saturation and CPAP pressure will be recorded before during and after the procedure. Complication like bradycardia (Hear rate below 100 beat per minute) or Apnea (pause of respiration for more than 20 second or less than 20 seconds but associated with bradycardia) All other neonatal outcome will be recorded (IVH \[Intra-ventricular Hemorrhage\], ROP \[Retinopathy of prematurity\], duration of ventilation, duration of hospital stay, infection, duration of oxygen requirement and others.

Interventions

DEVICEECALMIST

Labelled catheter at level of the lips (6 cm plus weight) will inserted through the vocal cords under direct vision using a standard laryngoscope without premedication while maintaining CPAP. 5 ml/kg surfactant syringe will be connected to the catheter hub and 0.25-0.5 ml was administered; then the syringe will be disconnected from the catheter to observe the surfactant moving up and down or coming back as indication of accurate intubation of the trachea. The surfactant the slowly administer by boluses of 0.25-0.5 ml over 20-30 seconds with 10 seconds apart. At the end of the procedure, the operator flushed the catheter with 0.5 ml of air before removing the catheter while maintaining CPAP

Sponsors

University of Manitoba
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
10 Minutes to 24 Hours
Healthy volunteers
No

Inclusion criteria

-preterm infants less than 35 weeks gestation in 1st day of life with RDS and spontaneously breathing on CPAP and need surfactant administration.

Exclusion criteria

* Infants needs of mechanical ventilation * Congenital anomaly * Respiratory distress due to non RDS related causes. * no parental consent

Design outcomes

Primary

MeasureTime frameDescription
Incidence of Early Ventilation Hours72 hoursThe need for mechanical ventilation due to various reasons like sepsis, Apnea (pause of respiration for more than 20 seconds) or Respiratory dysfunction evidenced by abnormal blood gas or desaturation or increase work of breathing

Secondary

MeasureTime frameDescription
Saturation During the Procedure10 minutesLevel of oxygen which is measured by oxygen pulse Oximetry. It is express as proportion out of one which is equal to percentage of 100. The number can be anywhere between 0.21 to 1 which is equal to percentage of 21 to 100.
Failure to Catheterized the Trachea by the Vascular Catheter20 secondsFailure define as inability to pass the vascular catheter to the trachea after 2 trials within 20 seconds time frame for each trial.
Index Before the Procedure1 hourThe index is an arbitrary number calculated by equation that is author defined which is(FiO2 \* CPAP/ Sat)\*100. FiO2: Fraction of inspired oxygen CPAP: continuous positive airway pressure Sat: saturation The equation is similar to the Oxygen index (OI) equation with replacement of Mean airway pressure (MAP) by continuous positive airway pressure (CPAP. It comprehensive view about the 3 parameters (FiO2, CPAP and Sat) during the procedure.
CPAP Pressure After the Procedure4 hoursContinuous positive airway pressure (CPAP) is measured in centimeter of water
Oxygen Requirement Before the Procedure1 hourOxygen requirement or FiO2 (Fraction of inspired oxygen) is expressed as proportion out of one (decimal) or percentage of 100. The number can be any where between 0.21 to 1 which is equal to percentage of 21 to 100.
Incidence of Bradycardia During ProcedureRange of 10 minutesBradycardia is persistent heart rate below 100 beat per minute for more than 20 seconds during the procedure as seen by the monitor or Heart rate below 60 beat per minute for any time if chest compression is needed or if associated with desaturation or apnea.
Index After the Procedure4 hoursThe index is an arbitrary number calculated by equation that is author defined which is(FiO2 \* CPAP/ Sat)\*100. FiO2: Fraction of inspired oxygen CPAP: continuous positive airway pressure Sat: saturation The equation is similar to the Oxygen index (OI) equation with replacement of Mean airway pressure (MAP) by continuous positive airway pressure (CPAP. It comprehensive view about the 3 parameters (FiO2, CPAP and Sat) during the procedure.
CPAP Pressure Before the Proceudre1 hourContinuous positive airway pressure (CPAP) pressure is measured in centimeter of water as recorded from CPAP machine (continuous positive airway pressure)
Oxygen Saturation Before the Procedure1 hourOxygen saturation is measured by pulse oximetry and express as proportion out of one which equal to percentage of 100. The number can be any where between 0.21 to 1 which is equal to percentage of 21 to 100.
Oxygen Requirements After the Procedure4 hoursOxygen requirement is expressed as proportion out of one (decimal) which is equal to percentage of 100. The measurment can be any where between 0.21 to 1 and this equal to percentage of 21-100%.
Needs for Intubation During the Procedure10 minutesThe needed for interruption or stop of ECALMIST to give PPV (positive pressure ventilation or mechanical ventilation though intubation by ETT (endotracheal intubation)
Oxygen Saturation After the Procedure4 hoursOxygen saturation is measured by pulse oximetry. It is express as proportion out of 1 (decimal) that is equal to percentage of 100. The number can be any where between 0.21 to 1 which is equal to percentage of 21 to 100.

Countries

Canada

Participant flow

Recruitment details

The recruitment period was of 2 months duration form July 5th, 2012 to September 5th, 2012 in 3 hospitals (St Boniface NICU, Children hospital's NICU and Women's hospital delivery room at HSC).

Participants by arm

ArmCount
Angiocath Surfactant
Preterm infants born at 24 to 34 weeks of postmenstrual gestational age were received surfactant by using technique called ECALMIST (Early CPAP And Large Volume Minimal Invasive Surfactant)
21
Total21

Baseline characteristics

CharacteristicAngiocath Surfactant
Age, Categorical
<=18 years
21 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
0 Participants
Age Continuous29 Weeks
STANDARD_DEVIATION 3
Region of Enrollment
Canada
21 participants
Sex: Female, Male
Female
12 Participants
Sex: Female, Male
Male
9 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
0 / 21
serious
Total, serious adverse events
3 / 21

Outcome results

Primary

Incidence of Early Ventilation Hours

The need for mechanical ventilation due to various reasons like sepsis, Apnea (pause of respiration for more than 20 seconds) or Respiratory dysfunction evidenced by abnormal blood gas or desaturation or increase work of breathing

Time frame: 72 hours

Population: The number of preterm infants that need intubation by ETT within 72 hours of life(early ventilation). This is includes all infants intubated whether during or after the ECALMIST procedure in the 1st 3 days of life (after delivery)

ArmMeasureValue (NUMBER)
Surfactant Administration Through Vascular CatheterIncidence of Early Ventilation Hours4 Number of participants
Secondary

CPAP Pressure After the Procedure

Continuous positive airway pressure (CPAP) is measured in centimeter of water

Time frame: 4 hours

Population: The mean of CPAP pressure express as centimeter of water of all participants after completion of ECALMIST

ArmMeasureValue (MEAN)Dispersion
Surfactant Administration Through Vascular CatheterCPAP Pressure After the Procedure5.8 Centimeter of waterStandard Deviation 0.471
Secondary

CPAP Pressure Before the Proceudre

Continuous positive airway pressure (CPAP) pressure is measured in centimeter of water as recorded from CPAP machine (continuous positive airway pressure)

Time frame: 1 hour

Population: The mean of CPAP pressure that is measured by centimeter of water of all the participant before ECALMIST

ArmMeasureValue (MEAN)Dispersion
Surfactant Administration Through Vascular CatheterCPAP Pressure Before the Proceudre7.1 Centimeter of waterStandard Deviation 0.447
Secondary

Failure to Catheterized the Trachea by the Vascular Catheter

Failure define as inability to pass the vascular catheter to the trachea after 2 trials within 20 seconds time frame for each trial.

Time frame: 20 seconds

Population: Number of infatns that failed to pass the angiocath to the trachea after 2 trials, 20 seconds each trial.

ArmMeasureValue (NUMBER)
Surfactant Administration Through Vascular CatheterFailure to Catheterized the Trachea by the Vascular Catheter1 Number of participants
Secondary

Incidence of Bradycardia During Procedure

Bradycardia is persistent heart rate below 100 beat per minute for more than 20 seconds during the procedure as seen by the monitor or Heart rate below 60 beat per minute for any time if chest compression is needed or if associated with desaturation or apnea.

Time frame: Range of 10 minutes

Population: The mean of heart beat per minute of all participants during ECALMIST(measured by minutes which is variable according participant tolerance of the ECALMIST procedure)

ArmMeasureValue (NUMBER)
Surfactant Administration Through Vascular CatheterIncidence of Bradycardia During Procedure3 Number of participants
Secondary

Index After the Procedure

The index is an arbitrary number calculated by equation that is author defined which is(FiO2 \* CPAP/ Sat)\*100. FiO2: Fraction of inspired oxygen CPAP: continuous positive airway pressure Sat: saturation The equation is similar to the Oxygen index (OI) equation with replacement of Mean airway pressure (MAP) by continuous positive airway pressure (CPAP. It comprehensive view about the 3 parameters (FiO2, CPAP and Sat) during the procedure.

Time frame: 4 hours

Population: The mean of ECALMIST index of all the participants after ECALMIST

ArmMeasureValue (MEAN)Dispersion
Surfactant Administration Through Vascular CatheterIndex After the Procedure1.27 ScoreStandard Deviation 1.8
Secondary

Index Before the Procedure

The index is an arbitrary number calculated by equation that is author defined which is(FiO2 \* CPAP/ Sat)\*100. FiO2: Fraction of inspired oxygen CPAP: continuous positive airway pressure Sat: saturation The equation is similar to the Oxygen index (OI) equation with replacement of Mean airway pressure (MAP) by continuous positive airway pressure (CPAP. It comprehensive view about the 3 parameters (FiO2, CPAP and Sat) during the procedure.

Time frame: 1 hour

Population: The mean of index of all participants before ECALMIST

ArmMeasureValue (MEAN)Dispersion
Surfactant Administration Through Vascular CatheterIndex Before the Procedure2.61 ScoreStandard Deviation 0.81
Secondary

Needs for Intubation During the Procedure

The needed for interruption or stop of ECALMIST to give PPV (positive pressure ventilation or mechanical ventilation though intubation by ETT (endotracheal intubation)

Time frame: 10 minutes

Population: The number of preterm infants that needed intubation by ETT (endotracheal intubation) during ECALMIST

ArmMeasureValue (NUMBER)
Surfactant Administration Through Vascular CatheterNeeds for Intubation During the Procedure3 Number of participants
Secondary

Oxygen Requirement Before the Procedure

Oxygen requirement or FiO2 (Fraction of inspired oxygen) is expressed as proportion out of one (decimal) or percentage of 100. The number can be any where between 0.21 to 1 which is equal to percentage of 21 to 100.

Time frame: 1 hour

Population: The mean of oxygen requirement of all the participants before ECALMIST

ArmMeasureValue (MEAN)Dispersion
Surfactant Administration Through Vascular CatheterOxygen Requirement Before the Procedure0.308 Proportion of oxygen requirementStandard Deviation 0.068
Secondary

Oxygen Requirements After the Procedure

Oxygen requirement is expressed as proportion out of one (decimal) which is equal to percentage of 100. The measurment can be any where between 0.21 to 1 and this equal to percentage of 21-100%.

Time frame: 4 hours

Population: The mean of oxygen level (proportion) of all participant after ECALMIST

ArmMeasureValue (MEAN)Dispersion
Surfactant Administration Through Vascular CatheterOxygen Requirements After the Procedure0.257 Proportion of oxygen saturationStandard Deviation 0.084
Secondary

Oxygen Saturation After the Procedure

Oxygen saturation is measured by pulse oximetry. It is express as proportion out of 1 (decimal) that is equal to percentage of 100. The number can be any where between 0.21 to 1 which is equal to percentage of 21 to 100.

Time frame: 4 hours

Population: The mean of oxygen saturation after ECALMIST for all the participants

ArmMeasureValue (MEAN)Dispersion
Surfactant Administration Through Vascular CatheterOxygen Saturation After the Procedure0.94 Proportion of oxygen saturationStandard Deviation 0.04
Secondary

Oxygen Saturation Before the Procedure

Oxygen saturation is measured by pulse oximetry and express as proportion out of one which equal to percentage of 100. The number can be any where between 0.21 to 1 which is equal to percentage of 21 to 100.

Time frame: 1 hour

Population: The mean of saturation of all participants before ECALMIST

ArmMeasureValue (MEAN)Dispersion
Surfactant Administration Through Vascular CatheterOxygen Saturation Before the Procedure0.87 Proportion of oxygen saturationStandard Deviation 0.08
Secondary

Saturation During the Procedure

Level of oxygen which is measured by oxygen pulse Oximetry. It is express as proportion out of one which is equal to percentage of 100. The number can be anywhere between 0.21 to 1 which is equal to percentage of 21 to 100.

Time frame: 10 minutes

Population: The mean of oxygen saturation of all participants during ECALMIST(measured by minutes which is variable according participant tolerance of the ECALMIST procedure)

ArmMeasureValue (MEAN)Dispersion
Surfactant Administration Through Vascular CatheterSaturation During the Procedure0.87 Proportion of oxygen saturationStandard Deviation 0.08

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026